A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD

NCT05113771 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

197

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment Resistant Depression

Interventions

DRUG: Liafensine
DRUG: Placebo

Sponsor

Denovo Biopharma LLC